<DOC>
	<DOCNO>NCT01315366</DOCNO>
	<brief_summary>The optimal dose vitamin D need optimize beneficial effect musculoskeletal outcome remain defined . Equally unclear impact vitamin D fuel metabolism insulin sensitivity human subject . Thus , overall objective proposal test hypothesis ambulatory overweight elderly individual , vitamin D administration dose high currently recommend : 1 . Have salutary effect parameter glucose fuel metabolism . It thus decrease index insulin resistance , improve lipid profile , decrease marker cardiovascular disease include adipokines , inflammatory cytokine , marker cell adhesion . 2 . Have superior effect indices mineral musculoskeletal metabolism , include bone remodel marker , lean mass , bone mineral density . We investigate whether effect modulate entry status vitaminD PTH detail</brief_summary>
	<brief_title>Hypovitaminosis D : A Link Between Bone/Mineral Fat/Fuel Metabolism</brief_title>
	<detailed_description>It become increasingly recognize low vitamin D level prevalent worldwide severe degree Middle East . Low vitamin D level associate increase risk osteoporotic fracture , chronic condition autoimmune disorder , diabetes , cancer , metabolic syndrome . Obese individual likely low vitamin D level , study obesity risk factor fracture young elderly . Our group investigate impact vitamin D therapy young , preliminary data suggest dos exceed currently update recommend estimate average requirement ( EAR ) 400IU age group may beneficial bone health . The updated EAR recommendation IOM age group , although believe cover need individual age group , limited lack good evidence support recommendation . Therefore , to-date , optimal dose vitamin D young elderly unknown . Two hundred fifty elderly ( age≥65 year ) , overweight ( BMI ≥25kg/m2 ) non-diabetic individual , recruit outpatient clinic investigator may access American University Beirut-Medical Center ( AUB-MC ) , Hotel Dieu de France ( HDF ) Rafic Hariri University Hospital ( RHUH ) , randomize pre-screen , double-blinded fashion , receive 500 IU equivalent 3357 IU vitamin D3 daily one year . Clinical information , exercise questionnaire obtain 0 12 months.In addition , subject partake original study offer option participate validity reliability study food frequency questionnaire ass dietary intake Ca , vitamins D K , participate vascular study evaluate relation nutrient vascular parameter . Information educational level , insurance status , dietary , sunscreen use , sun exposure skin pigmentation obtain baseline . Information fall , trauma , history fracture medication obtain visit ( 0 , 3 , 6 12 month ) . The measurement height , weight , BMI , waist , hip , waist/hip ratio , mid arm circumference , mid-calf circumference muscle strength subject , enrol study , triplicate visit 0,3,6 12 month . Blood pressure heart rate measure screening , baseline , 3 month , 6 month 12 month . Blood drawn baseline , 3 , 6 12 month measurement serum creatinine , calcium , phosphorous , alkaline phosphatase , 25-OHD , 1,25 ( OH ) 2D , PTH , indices bone remodeling ( osteocalcin crosslaps ) , second morning void urine specimen collect Ca/Cr . Insulin resistance measure use McAuley well HOMA QUCKI index . We also measure serum level adipokines ( adiponectin , leptin ) , DLK1-Pref1 , inflammatory marker ( CRP , IL-6 ) adhesion molecule ( sICAM , sVCAM ) . We characterize polymorphisms gene affect mineral metabolism VDR , CaSR , ER CYP2R1 , measure adiponectin R expression subcutaneous fat muscle biopsy obtain 0 12 months.Bone density scan Lumbar Spine , Femoral Neck , Total Hip , Total Body , Sub Total Body , body composition hip structural analysis parameter well TBS variable spine obtain baseline 12 month study . A visit 9 month schedule supply subject Ci-cal D Euro D , ensure compliance . IRB approval consent form obtain . An independent Data Safety Monitoring Board ask review serious adverse event need may ask review unblinded data recruitment 30 % , 60 % 100 % study subject serious adverse event form throughout study duration.Repeated measure analysis use evaluate difference outcomes interest two treatment group time effect within treatment arm .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Avitaminosis</mesh_term>
	<mesh_term>Rickets</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Elderly subject ( &gt; equal 65 year old ) without disease mention exclusion criterion . BMI ≥ 25Kg/meters square Exclusion criterion include : diabetes , subject impair glucose tolerance medication , presence chronic disease major organ failure severe heart failure , kidney liver failure , condition intake medication know affect bone metabolism , rickets osteomalacia , history kidney stone , baseline vitamin D level le 10 ng/ml history fragility fracture overall fracture risk base FRAX &gt; 10 % . Subjects impair glucose tolerance medication exclude . The classification individual diabetic impair glucose tolerance base American Diabetes Association criterion diagnosis .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Elderly</keyword>
	<keyword>Cardiovascular profile</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Gene polymorphism</keyword>
</DOC>